Suppr超能文献

[微小RNA调控通路中基因变异的研究进展]

[Progress in research on genetic variations in miRNA regulatory pathway].

作者信息

Guo Zhen, Zhou Honghao, Zhang Wei

机构信息

Department of Clinical Pharmacology, Xiangya Hospital, Institute of Clinical Pharmacology, Central South University, Changsha, Hunan 410078, P. R. China. Email:

出版信息

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Feb;32(1):109-12. doi: 10.3760/cma.j.issn.1003-9406.2015.01.024.

Abstract

MicroRNAs (miRNAs) are a class of highly conserved small noncoding RNAs which can regulate gene expression by post-transcriptional degradation or translational repression. miRNAs are involved in the regulation of cell apoptosis, proliferation, differentiation and other physiological processes, and are closely related with development of cancer. More recently, it has been proposed that the presence of genetic variations in microRNA genes, their biogenesis pathway and target binding sites can affect the miRNA processing machinery and targeting, therefore have a significant genetic effect. Since polymorphisms in a miRNA regulatory pathway can result in the loss or gain of a miRNA function and can affect the expression of hundreds of genes, more and more evidence suggested a strong association of miRNA polymorphisms with disease progression, diagnosis and prognosis. Whether in the pathogenesis research of complex diseases or finding biomarkers for diagnosis and prognosis, polymorphisms in the miRNA regulatory pathway have an extremely important value for research.

摘要

微小RNA(miRNA)是一类高度保守的小非编码RNA,其可通过转录后降解或翻译抑制来调节基因表达。miRNA参与细胞凋亡、增殖、分化及其他生理过程的调控,并与癌症的发生发展密切相关。最近,有人提出微小RNA基因、其生物合成途径及靶标结合位点中的遗传变异的存在可影响miRNA加工机制和靶向作用,因此具有显著的遗传效应。由于miRNA调控途径中的多态性可导致miRNA功能的丧失或获得,并可影响数百个基因的表达,越来越多的证据表明miRNA多态性与疾病进展、诊断及预后密切相关。无论是在复杂疾病的发病机制研究中,还是在寻找诊断和预后的生物标志物方面,miRNA调控途径中的多态性都具有极其重要的研究价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验